FDA Inspection 1121115 — LifeCell Corporation, A Wholly Owned Subsidiary Of Allergan PLC

LifeCell Corporation, A Wholly Owned Subsidiary Of Allergan PLC — FEI 3008307571

The FDA completed an inspection of LifeCell Corporation, A Wholly Owned Subsidiary Of Allergan PLC on Feb 20, 2020 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 20, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Branchburg, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.